H Tsubouchi
Overview
Explore the profile of H Tsubouchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
2045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baba A, Maki Y, Kanekura T, Tsubouchi H
J Eur Acad Dermatol Venereol
. 2022 Jul;
36(12):e982-e983.
PMID: 35841297
No abstract available.
2.
Saeki H, Baba N, Ito K, Yokota D, Tsubouchi H
Br J Dermatol
. 2021 Jul;
186(1):40-49.
PMID: 34289086
Background: In atopic dermatitis (AD), phosphodiesterase 4 (PDE4) inhibition reduces proinflammatory mediators and cytokines. Difamilast is a new selective PDE4 inhibitor. Objectives: To demonstrate the superiority of topical difamilast to...
3.
Ohmure H, Sakoguchi Y, Nagayama K, Numata M, Tsubouchi H, Miyawaki S
J Oral Rehabil
. 2014 Mar;
41(6):423-31.
PMID: 24655114
Recent studies have been revealing the relationship between the stomatognathic system and the gastrointestinal tract. However, the effect of oesophageal acid stimulation on masticatory muscle activity during wakefulness has not...
4.
Nagatomo Y, Okayama A, Murai K, Sasaki T, Kuroki M, Tanaka G, et al.
Mod Rheumatol
. 2014 Jan;
10(3):165-8.
PMID: 24383595
Abstract A 36-year-old male patient with dermatomyo-sitis (DM) associated with rapidly progressive interstitial pneumonia (IP) was successfully treated by high-dose intravenous immunoglobulin (IVIG). He suffered from myopathy, skin lesions, and...
5.
Nakamura T, Shiraki M, Fukunaga M, Tomomitsu T, Santora A, Tsai R, et al.
Osteoporos Int
. 2013 May;
25(1):367-76.
PMID: 23716037
Unlabelled: The efficacy and safety of oral placebo or odanacatib 10, 25, or 50 mg once weekly for 52 weeks were evaluated in a double-blind, randomized, multi-center study in Japanese...
6.
Hayashi N, Okanoue T, Tsubouchi H, Toyota J, Chayama K, Kumada H
J Viral Hepat
. 2012 Jan;
19(2):e134-42.
PMID: 22239511
The aims of this phase III study were to assess the efficacy and safety of telaprevir in combination with peginterferon alfa-2b (PEG-IFN) and ribavirin (RBV) for difficult-to-treat patients who had...
7.
Ohmure H, Takada H, Nagayama K, Sakiyama T, Tsubouchi H, Miyawaki S
J Dent Res
. 2011 Dec;
91(3):293-8.
PMID: 22205636
Because various mastication-related factors influence gastric activity, the functional relationship between mastication and gastric function has not been fully elucidated. To investigate the influence of mastication on gastric emptying and...
8.
Yokozaki H, Ito M, Yasui W, Kyo E, Kuniyasu H, Kitadai Y, et al.
Int J Oncol
. 2011 May;
3(1):89-93.
PMID: 21573331
Biologic effect of human hepatocyte growth factor (hHGF), which is now known to be the same protein of scatter factor and tumor cytotoxic factor, on gastric cancer cell lines were...
9.
Ohmure H, Oikawa K, Kanematsu K, Saito Y, Yamamoto T, Nagahama H, et al.
J Dent Res
. 2011 Jan;
90(5):665-71.
PMID: 21248360
Unlabelled: The aim of this cross-over, randomized, single-blinded trial was to examine whether intra-esophageal acidification induces sleep bruxism (SB). Polysomnography with electromyogram (EMG) of masseter muscle, audio-video recording, and esophageal...
10.
Egawa H, Ueda Y, Ichida T, Teramukai S, Nakanuma Y, Onishi S, et al.
Am J Transplant
. 2011 Jan;
11(3):518-27.
PMID: 21219581
The outcomes of primary sclerosing cholangitis (PSC) after living donor liver transplantation (LDLT) in a large series have not been reported. We aimed to determine long-term patient and graft survival,...